Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
3 habits of the happiest people
Think of the happiest people you know. Do you find yourself often wondering what they are doing to maintain a general level of joy? ...
Read More‘Tis the season to land your ideal job: 5 expert techniques to improve ...
The holiday season isn't only about making merry and meeting with family and friends; it's also an excellent time to ramp up your job ...
Read MoreA personalized mRNA Vaccine provides ‘real hope’ for melanoma pat...
BY THE OPTIMIST DAILY EDITORIAL TEAM In a major development in cancer research, scientists started testing the world's first tailored mRNA cancer vaccine for ...
Read MoreLondon Doctors cure childhood blindness with cutting-edge gene therapy
BY THE OPTIMIST DAILY EDITORIAL TEAM Doctors in London have successfully restored sight in children born with a rare form of blindness, using a ...
Read More
